Peptides for Anxiety and Depression: Selank, Semax, and Beyond

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Selank and Semax are Russian-developed peptides with strong anxiolytic and antidepressant properties. Selank modulates GABA and serotonin systems; Semax boosts BDNF and dopamine. Both have favorable safety profiles and are used intranasally.

The Neuropeptide Revolution in Mental Health

Mental health disorders affect hundreds of millions of people worldwide, yet conventional pharmacological treatments leave many patients with inadequate relief, significant side effects, or both. Neuropeptides offer a compelling alternative, working through mechanisms that are fundamentally different from conventional psychotropics and often with superior tolerability profiles.

Selank: The Anxiolytic Peptide

Selank is a synthetic heptapeptide analogue of tuftsin, approved as a pharmaceutical drug in Russia for the treatment of anxiety disorders. Its anxiolytic effects are mediated through multiple pathways: it modulates the GABAergic system, regulates serotonin metabolism, and influences enkephalin degradation. Unlike benzodiazepines, Selank does not cause sedation, cognitive impairment, or physical dependence. Clinical studies have shown Selank to be as effective as phenazepam for generalized anxiety disorder with a dramatically better side effect profile. Typical dosing: 250–500 mcg intranasally, 2–3 times daily.

Semax: Cognitive Enhancement and Antidepressant Effects

Semax is a synthetic analogue of the ACTH 4-10 fragment, approved in Russia as a pharmaceutical. Its primary mechanism involves upregulation of Brain-Derived Neurotrophic Factor (BDNF), which promotes neuroplasticity, neurogenesis, and the survival of existing neurons. BDNF deficiency is strongly implicated in depression and anxiety. By boosting BDNF, Semax addresses one of the root neurobiological causes of these conditions. Typical dosing: 200–600 mcg intranasally, 1–2 times daily.

Combining Selank and Semax

These two peptides are frequently stacked together, with Selank providing acute anxiolytic relief and Semax offering longer-term neuroplasticity and mood enhancement. A common protocol involves Selank in the morning for anxiety management and Semax later in the day for cognitive enhancement and antidepressant effects.

Conclusion

Neuropeptides like Selank and Semax represent a genuinely novel approach to mental health — one that works with the brain's own regulatory systems to restore balance rather than imposing a pharmacological override. For individuals who have not found adequate relief with conventional treatments, these peptides merit serious consideration.